Key facts
- It has raised $2.8M; the latest was Seed Round ($2.3M) in May 2025.
- Notable investors include ROM Utrecht Region, Nina Capital, Utrecht Health Seed Fund, Utrechtinc, Value Creation Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for CryoCloud
- ·The full record, as it builds
Funding rounds
No funding rounds for CryoCloud are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CryoCloud
Developer of a cloud-based data analysis platform designed for cryo-EM research purposes. The company's platform provides instant access to advanced computational resources, image analysis workflows, and secure storage options, enabling researchers and scientists to streamline data processing and eliminate hardware maintenance in protein structure determination.
- Sector
- Healthcare
- HQ
- Utrecht, Netherlands
- Founded
- 2021
- Employees
- 7
- Website
- cryocloud.io/
- Ownership
- Privately Held (backing)
CryoCloud doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CryoCloud shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CryoCloud in its N-PORT filings yet. We sweep new filings monthly.